The DNA damage checkpoint is activated during residual tumour cell survival to methotrexate treatment as an initial step of acquired drug resistance

  1. De Anta, J.M.
  2. Pérez-Castro, A.J.
  3. Freire, R.
  4. Mayol, X.
Revista:
Anti-Cancer Drugs

ISSN: 0959-4973

Any de publicació: 2006

Volum: 17

Número: 10

Pàgines: 1171-1177

Tipus: Article

DOI: 10.1097/01.CAD.0000236311.73703.D2 GOOGLE SCHOLAR
Font de les dades: Scopus